Towards Implementation of Equitable and Effective Non-Communicable Disease Policies; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

Document Type : Commentary

Authors

1 University Children’s Hospital, University of Zurich, Zurich, Switzerland

2 Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland

3 Renal Division, Brigham and Women’s Hospital, Boston, MA, USA

4 Harvard Medical School, Boston, MA, USA

5 Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

6 Kidney Health Program, Ministry of Public Health and Social Assistance, Guatemala City, Guatemala

Abstract

Non-communicable diseases (NCDs) have been the leading global causes of death and disease burden over the past two decades, but policies and actions to reduce these burdens have been insufficient. Many NCDs are preventable through the implementation of the World Health Organization (WHO) Best Buys – which initially focused on cardiovascular disease, cancer, respiratory disease, and diabetes. Implementing these interventions is complex, requiring transparent and appropriate policy development, policy implementation, and tracking of impact. Barriers to successful implementation are multiple and highly contextual, suchcountry fragility, loci of power, and external pressures. Implementation research is required to identify local barriers and develop strategies to optimize policy implementation to maximize success. Success relies on availability of robust data to permit priority setting, especially where resources are limited, and equitable allocation of healthcare resources to tackle the leading burdens of disease in local contexts. Policy-making must look beyond health to ensure a multisectoral approach to enhancing well-being and sustainability. Global solidarity is required to ensure no countries and no diseases are left behind.

Keywords


  1. World Health Organization (WHO). Global Excess Deaths Associated with COVID-19, January 2020 - December 2021. A Comprehensive View of Global Deaths Directly and Indirectly Associated with the COVID-19 Pandemic. WHO; 2022. https://www.who.int/data/stories/global-excess-deaths-associated-with-covid-19-january-2020-december-2021. Accessed December14, 2022.
  2. World Health Organization (WHO). Fact Sheet: Noncommunicable Diseases. WHO; 2024. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed October 2, 2025.
  3. United Nations. The Millennium Development Goals Report. New York: United Nations; 2015.
  4. Jailobaeva K, Falconer J, Loffreda G, Arakelyan S, Witter S, Ager A. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries. Global Health. 2021;17(1):68. doi:1186/s12992-021-00713-4
  5. Fofana MO. Decolonising global health in the time of COVID-19. Glob Public Health. 2021;16(8-9):1155-1166. doi:1080/17441692.2020.1864754
  6. Luna F, Luyckx VA. Why have non-communicable diseases been left behind? Asian Bioeth Rev. 2020;12(1):5-25. doi:1007/s41649-020-00112-8
  7. Nishtar S, Niinistö S, Sirisena M, et al. Time to deliver: report of the WHO Independent High-Level Commission on NCDs. Lancet. 2018;392(10143):245-252. doi:10.1016/s0140-6736(18)31258-3
  8. World Health Organization (WHO). Tackling NCDs: Best Buys and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases. 2nd ed. WHO; 2024. https://www.who.int/publications/i/item/9789240091078. Accessed October 2, 2025.
  9. United Nations. The Sustainable Development Goals Report 2024. United Nations; 2024. https://unstats.un.org/sdgs/report/2024/. Accessed October 2, 2025.
  10. Schwartz LN, Shaffer JD, Bukhman G. The origins of the 4 × 4 framework for noncommunicable disease at the World Health Organization. SSM Popul Health. 2021;13:100731. doi:1016/j.ssmph.2021.100731
  11. Loffreda G, Arakelyan S, Bou-Orm I, et al. Barriers and opportunities for WHO "Best Buys" non-communicable disease policy adoption and implementation from a political economy perspective: a complexity systematic review. Int J Health Policy Manag. 2024;13:7989. doi:34172/ijhpm.2023.7989
  12. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090. doi:1016/s0140-6736(18)31694-5
  13. Bukhman G, Mocumbi AO, Atun R, et al. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. Lancet. 2020;396(10256):991-1044. doi:1016/s0140-6736(20)31907-3
  14. Stutzin Donoso F. Chronic disease as risk multiplier for disadvantage. J Med Ethics. 2018;44(6):371-375. doi:1136/medethics-2017-104321
  15. World Health Organization (WHO). Saving Lives, Spending Less: A Strategic Response to Noncommunicable Diseases. WHO; 2018. https://www.who.int/publications/i/item/WHO-NMH-NVI-18.8. Accessed December 11, 2018.

Articles in Press, Corrected Proof
Available Online from 14 October 2025
  • Received Date: 04 March 2025
  • Revised Date: 13 September 2025
  • Accepted Date: 14 September 2025
  • First Published Date: 15 September 2025
  • Published Date: 14 October 2025